封面
市场调查报告书
商品编码
1613263

全球DNA修復药物市场(依药物类型、剂型、作用机制、应用、通路):未来预测(2025-2030)

DNA Repair Drugs Market by Drug Type (Alkylating Agents, Poly ADP Ribose Polymerase Inhibitors), Form (Capsules, Injectables, Tablets), Mechanism of Action, Application, Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年DNA修復药物市值为85.8亿美元,预计2024年将达到91.8亿美元,复合年增长率为7.20%,到2030年将达到139.7亿美元。

DNA修復药物市场主要涉及旨在修復受损DNA以治疗各种遗传疾病和癌症的治疗药物的开发和商业化。对此类药物的需求是由环境因素和生活方式改变引起的癌症和基因突变的日益流行所推动的。 DNA修復药物主要应用于肿瘤学,以恢復正常细胞功能,对于治疗乳癌、卵巢和前列腺癌等癌症至关重要。最终用途范围包括医院、专科诊所和研究机构,重点是推进治疗性介入。影响成长的关键因素包括製药公司增加研发投资、对遗传疾病的更好理解以及实现精准医疗的技术进步。对个人化医疗的日益关注代表着一个重大的商机,因为个人的遗传讯息可用于提供量身定制的治疗并改善患者的治疗结果。然而,市场开拓面临开发成本高、监管核准流程冗长等限制。基因改造也存在潜在副作用和伦理问题等挑战。

主要市场统计
基准年[2023] 85.8亿美元
预测年份 [2024] 91.8亿美元
预测年份 [2030] 139.7亿美元
复合年增长率(%) 7.20%

也就是说,存在一些潜在的机会。公司可以考虑与生物技术公司合作,结合专业知识并加速创新和产品开发。投资 CRISPR 和人工智慧药物发现等最尖端科技可以开发更精确的治疗方法并提供竞争优势。将 DNA 修復药物与免疫疗法和标靶治疗结合的联合治疗的研究可能会扩大治疗的可能性。创新应着重于提高药物疗效,同时最大限度地减少副作用,确保药物易于取得且具成本效益。市场本质上是在不断发展的,因此保持敏捷非常重要。企业需要随时了解最新的监管指南和新兴趋势,以利用市场变化。

市场动态:揭示快速发展的 DNA 修復药物市场的关键市场洞察

DNA 修復药物市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界上慢性病和遗传疾病的增加
    • 扩大临床试验和研发以促进发展
    • 政府努力促进复杂疾病的治疗
  • 市场限制因素
    • DNA修復药物的配方问题与复杂性
  • 市场机会
    • 持续创新,提高DNA修復药物的功效与安全性
    • 消费者偏好个人化和精细化策略来管理复杂疾病
  • 市场挑战
    • 与功效和安全性问题相关的限制

波特五力:驾驭 DNA 修復药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。它为评估公司的竞争力和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战,以确保更强大的市场地位。

PESTLE分析:了解 DNA 修復药物市场的外部影响

外部宏观环境因素在塑造 DNA 修復药物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析:了解DNA修復药物市场的竞争格局

DNA 修復药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵:DNA 修復药物市场供应商的绩效评估

FPNV定位矩阵是评估DNA修復药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议:规划 DNA 修復药物市场的成功之路

对于旨在加强在全球市场的影响力的公司来说,对 DNA 修復药物市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估市场范围和整体影响力。

2. 市场开发:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析最近的产品发布、开拓的地区、关键产业进展以及塑造市场的策略投资。

4. 竞争评估与情报:全面分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1. 目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3. 塑造市场的关键技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 哪些收益来源和策略机会推动供应商的进入/退出策略?

目录

第一章简介

第二章 分析方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和遗传疾病的发生率正在增加
      • 扩大临床试验和研究倡议以开发 DNA 修復药物
      • 政府努力促进复杂疾病的治疗
    • 抑制因素
      • DNA修復药物配方的问题与复杂性
    • 机会
      • 持续创新提高DNA修復药物的功效与安全性
      • 消费者偏好个人化和精确的策略来管理复杂疾病
    • 任务
      • 与功效和安全性问题相关的限制
  • 市场区隔分析
    • 剂型:显着引入用于快速给药的注射剂
    • 应用:扩大DNA修復药物治疗在肿瘤标靶给药的应用
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 经济因素
    • 社会因素
    • 技术因素
    • 法律因素
    • 环境因素

第六章 DNA 修復药物市场:依药物类型

  • 烷化剂
  • 聚 ADP 核糖聚合酵素抑制剂

第7章 DNA修復药物市场:按形态

  • 胶囊
  • 注射
  • 药片

第八章 DNA修復药物市场:按作用机制

  • 碱基切除修復调节剂
  • 双链修復调节器
  • 失配修復调节器
  • 单链修復调节器

第九章 DNA修復药物市场:依应用分类

  • 神经系统疾病
    • 乳癌
    • 卵巢癌
    • 摄护腺癌

第10章DNA修復药物市场:依分销管道分类

  • 医院药房
  • 网路药房

第十一章 北美、南美DNA修復药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章 亚太地区DNA修復药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东、非洲DNA修復药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 市场占有率分析(2023)
  • FPNV定位矩阵(2023)
  • 竞争情境分析
    • 默克与江苏恆瑞药业有限公司合作彻底改变癌症治疗
    • F. Hoffmann-La Roche AG 与 KSQ Therapeutics, Inc. 在癌症治疗 DNA 修復药物方面的合作与创新
    • FDA核准新的联合治疗携带基因突变的进行性前列腺癌
  • 战略分析和建议

公司名单

  • Artios Pharma
  • AstraZeneca PLC
  • Aurigene Discovery Technologies
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • CanBas Co., Ltd.
  • Clovis Oncology
  • Corden Pharma International GmbH
  • Eli Lilly and Company
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Hanson Wade Group
  • Johnson & Johnson Services, Inc.
  • Merck KgaA
  • Novartis AG
  • Pfizer Inc.
  • Valerio Therapeutics
Product Code: MRR-99555D550531

The DNA Repair Drugs Market was valued at USD 8.58 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 7.20%, to USD 13.97 billion by 2030.

The DNA repair drugs market primarily involves the development and commercialization of therapeutics aimed at repairing damaged DNA to treat various genetic disorders and cancers. The necessity for these drugs is driven by the increasing prevalence of cancer and genetic mutations, often stemming from environmental factors and lifestyle changes. DNA repair drugs find application primarily in oncology to restore the normal functioning of cells and are integral in treating cancers such as breast, ovarian, and prostate cancer. The end-use scope encompasses hospitals, specialized clinics, and research institutes that focus on advancing therapeutic interventions. Key influencing growth factors include the rising investments in R&D by pharmaceuticals, an increasing understanding of genetic disorders, and advancements in technology enabling precision medicine. The burgeoning focus on personalized medicine presents a significant opportunity, as leveraging individual genetic information can lead to customized therapies, improving patient outcomes. However, the market faces limitations such as high development costs and lengthy regulatory approval processes. Challenges also include potential side effects and ethical concerns regarding genetic modifications.

KEY MARKET STATISTICS
Base Year [2023] USD 8.58 billion
Estimated Year [2024] USD 9.18 billion
Forecast Year [2030] USD 13.97 billion
CAGR (%) 7.20%

Nevertheless, there are several potential opportunities. Companies should consider partnerships with biotech firms to combine expertise, which could fast-track innovation and product development. Investment in cutting-edge technologies like CRISPR and AI-driven drug discovery could lead to more precise treatment modalities and provide a competitive edge. Research into combination therapies that incorporate DNA repair drugs with immunotherapies or targeted therapies may expand therapeutic potential. Innovation should focus on increasing drug efficacy while minimizing adverse effects, ensuring drugs are accessible and cost-effective. The market is inherently fast-evolving, so maintaining agility is key; firms should stay updated on regulatory guidelines and emerging trends to capitalize on market shifts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA Repair Drugs Market

The DNA Repair Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of chronic and genetic diseases across the world
    • Expanding clinical trials and research initiatives to develop DNA repair drugs
    • Government initiatives to promote access to treatments for complex diseases
  • Market Restraints
    • Formulation issues and complexities of DNA repair drugs
  • Market Opportunities
    • Ongoing innovations to improve the efficacy and safety of DNA repair drugs
    • Consumer preference for personalized and precision strategies to manage complex diseases
  • Market Challenges
    • Limitations associated with efficacy and safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the DNA Repair Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA Repair Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA Repair Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA Repair Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA Repair Drugs Market

A detailed market share analysis in the DNA Repair Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA Repair Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA Repair Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA Repair Drugs Market

A strategic analysis of the DNA Repair Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA Repair Drugs Market, highlighting leading vendors and their innovative profiles. These include Artios Pharma, AstraZeneca PLC, Aurigene Discovery Technologies, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CanBas Co., Ltd., Clovis Oncology, Corden Pharma International GmbH, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline PLC, Hanson Wade Group, Johnson & Johnson Services, Inc., Merck KgaA, Novartis AG, Pfizer Inc., and Valerio Therapeutics.

Market Segmentation & Coverage

This research report categorizes the DNA Repair Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Alkylating Agents and Poly ADP Ribose Polymerase Inhibitors.
  • Based on Form, market is studied across Capsules, Injectables, and Tablets.
  • Based on Mechanism of Action, market is studied across Base Excision Repair Modulators, Double-strand Break Repair Modulators, Mismatch Repair Modulators, and Single-strand Break Repair Modulators.
  • Based on Application, market is studied across Neurological Diseases and Oncology. The Oncology is further studied across Breast Cancer, Ovarian Cancer, and Prostate Cancer.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Online Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of chronic and genetic diseases across the world
      • 5.1.1.2. Expanding clinical trials and research initiatives to develop DNA repair drugs
      • 5.1.1.3. Government initiatives to promote access to treatments for complex diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Formulation issues and complexities of DNA repair drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the efficacy and safety of DNA repair drugs
      • 5.1.3.2. Consumer preference for personalized and precision strategies to manage complex diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with efficacy and safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Significant adoption of injectables for quick delivery of medication
    • 5.2.2. Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. DNA Repair Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Alkylating Agents
  • 6.3. Poly ADP Ribose Polymerase Inhibitors

7. DNA Repair Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Injectables
  • 7.4. Tablets

8. DNA Repair Drugs Market, by Mechanism of Action

  • 8.1. Introduction
  • 8.2. Base Excision Repair Modulators
  • 8.3. Double-strand Break Repair Modulators
  • 8.4. Mismatch Repair Modulators
  • 8.5. Single-strand Break Repair Modulators

9. DNA Repair Drugs Market, by Application

  • 9.1. Introduction
  • 9.2. Neurological Diseases
  • 9.3. Oncology
    • 9.3.1. Breast Cancer
    • 9.3.2. Ovarian Cancer
    • 9.3.3. Prostate Cancer

10. DNA Repair Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies

11. Americas DNA Repair Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific DNA Repair Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa DNA Repair Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations
    • 14.3.2. Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs
    • 14.3.3. FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Artios Pharma
  • 2. AstraZeneca PLC
  • 3. Aurigene Discovery Technologies
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bristol-Myers Squibb Company
  • 6. CanBas Co., Ltd.
  • 7. Clovis Oncology
  • 8. Corden Pharma International GmbH
  • 9. Eli Lilly and Company
  • 10. Genentech, Inc.
  • 11. GlaxoSmithKline PLC
  • 12. Hanson Wade Group
  • 13. Johnson & Johnson Services, Inc.
  • 14. Merck KgaA
  • 15. Novartis AG
  • 16. Pfizer Inc.
  • 17. Valerio Therapeutics

LIST OF FIGURES

  • FIGURE 1. DNA REPAIR DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. DNA REPAIR DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DNA REPAIR DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DNA REPAIR DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023